INCYTE CORPORATION Finite-Lived Intangible Assets, Accumulated Amortization
INCYTE CORPORATION (INCY) had Finite-Lived Intangible Assets, Accumulated Amortization of $34.10 million as of 2017-12-31, per its 10-K filed 2018-02-15.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization · last filed 2018-02-15
- 2017-12-31: Finite-Lived Intangible Assets, Accumulated Amortization $34.10M.
- 2017-09-30: Finite-Lived Intangible Assets, Accumulated Amortization $28.71M.
- 2017-06-30: Finite-Lived Intangible Assets, Accumulated Amortization $23.33M.
- 2017-03-31: Finite-Lived Intangible Assets, Accumulated Amortization $17.95M.
| Period end | Finite-Lived Intangible Assets, Accumulated Amortization |
|---|---|
| 2017-12-31 | $34.10M 10-K · filed 2018-02-15 |
| 2017-09-30 | $28.71M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $23.33M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $17.95M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $12.56M 10-K · filed 2018-02-15 |
| 2016-09-30 | $7.18M 10-Q · filed 2016-11-01 |
| 2016-06-30 | $1.79M 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| IQVIA HOLDINGS INC. (IQV) | United States | $45.926B | 20.54 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |